Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report)
Aim of the study. To evaluate the risk factors for the occurrence of intramuscular hematomas in patients with severe coronavirus infection receiving anticoagulant therapy.Materials and methods. Intramuscular hematomas in five patients with severe COVID-19 disease are reported in the paper. The crite...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2022-02-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/2178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850029194353836032 |
|---|---|
| author | N. A. Lesteva G. Yu. Rybakov I. N. Danilov A. A. Kovalev A. N. Kondratyev |
| author_facet | N. A. Lesteva G. Yu. Rybakov I. N. Danilov A. A. Kovalev A. N. Kondratyev |
| author_sort | N. A. Lesteva |
| collection | DOAJ |
| description | Aim of the study. To evaluate the risk factors for the occurrence of intramuscular hematomas in patients with severe coronavirus infection receiving anticoagulant therapy.Materials and methods. Intramuscular hematomas in five patients with severe COVID-19 disease are reported in the paper. The criteria for selecting patients for the study included respiratory distress requiring oxygen, radiographic signs of severe pneumonia, anticoagulant therapy using low molecular weight heparin (LMWH), and spontaneous intramuscular hematoma. Clinical manifestations, blood coagulation results, conservative and surgical management were analyzed.Results. Standard regimen anticoagulation therapy in patients with coronavirus infection requires vigilance because of a risk of development of hemorrhagic complications.Сonclusion. When assessing a patient with hematomas, an emphasis should be given to examination of patients and changes in hemoglobin and hematocrit levels. Best strategy of anticoagulant therapy for patients with coronavirus infection and high risk of VTE, as well as optimal laboratory monitoring during LMWH administration are yet to be explored. |
| format | Article |
| id | doaj-art-c318f67ae2584ef29c44abd9fffd7d06 |
| institution | DOAJ |
| issn | 1813-9779 2411-7110 |
| language | English |
| publishDate | 2022-02-01 |
| publisher | Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia |
| record_format | Article |
| series | Общая реаниматология |
| spelling | doaj-art-c318f67ae2584ef29c44abd9fffd7d062025-08-20T02:59:35ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102022-02-01181233010.15360/1813-9779-2022-1-23-301833Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report)N. A. Lesteva0G. Yu. Rybakov1I. N. Danilov2A. A. Kovalev3A. N. Kondratyev4V. A. Almazov National Medical Research Center, Ministry of Health of RussiaV. A. Almazov National Medical Research Center, Ministry of Health of RussiaV. A. Almazov National Medical Research Center, Ministry of Health of RussiaV. A. Almazov National Medical Research Center, Ministry of Health of RussiaV. A. Almazov National Medical Research Center, Ministry of Health of RussiaAim of the study. To evaluate the risk factors for the occurrence of intramuscular hematomas in patients with severe coronavirus infection receiving anticoagulant therapy.Materials and methods. Intramuscular hematomas in five patients with severe COVID-19 disease are reported in the paper. The criteria for selecting patients for the study included respiratory distress requiring oxygen, radiographic signs of severe pneumonia, anticoagulant therapy using low molecular weight heparin (LMWH), and spontaneous intramuscular hematoma. Clinical manifestations, blood coagulation results, conservative and surgical management were analyzed.Results. Standard regimen anticoagulation therapy in patients with coronavirus infection requires vigilance because of a risk of development of hemorrhagic complications.Сonclusion. When assessing a patient with hematomas, an emphasis should be given to examination of patients and changes in hemoglobin and hematocrit levels. Best strategy of anticoagulant therapy for patients with coronavirus infection and high risk of VTE, as well as optimal laboratory monitoring during LMWH administration are yet to be explored.https://www.reanimatology.com/rmt/article/view/2178intramuscular hematomaanticoagulant therapycoronavirus infection |
| spellingShingle | N. A. Lesteva G. Yu. Rybakov I. N. Danilov A. A. Kovalev A. N. Kondratyev Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) Общая реаниматология intramuscular hematoma anticoagulant therapy coronavirus infection |
| title | Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) |
| title_full | Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) |
| title_fullStr | Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) |
| title_full_unstemmed | Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) |
| title_short | Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) |
| title_sort | spontaneous intramuscular hematomas in patients with severe covid 19 case report |
| topic | intramuscular hematoma anticoagulant therapy coronavirus infection |
| url | https://www.reanimatology.com/rmt/article/view/2178 |
| work_keys_str_mv | AT nalesteva spontaneousintramuscularhematomasinpatientswithseverecovid19casereport AT gyurybakov spontaneousintramuscularhematomasinpatientswithseverecovid19casereport AT indanilov spontaneousintramuscularhematomasinpatientswithseverecovid19casereport AT aakovalev spontaneousintramuscularhematomasinpatientswithseverecovid19casereport AT ankondratyev spontaneousintramuscularhematomasinpatientswithseverecovid19casereport |